These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 27128905)

  • 1. In Vivo Delivery Systems for Therapeutic Genome Editing.
    Wang L; Li F; Dang L; Liang C; Wang C; He B; Liu J; Li D; Wu X; Xu X; Lu A; Zhang G
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Delivery Vehicles for Genome Editing.
    Nelson CE; Gersbach CA
    Annu Rev Chem Biomol Eng; 2016 Jun; 7():637-62. PubMed ID: 27146557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing and CRISPR in the clinic: current and future perspectives.
    Hirakawa MP; Krishnakumar R; Timlin JA; Carney JP; Butler KS
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32207531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
    Guha TK; Edgell DR
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INDEL detection, the 'Achilles heel' of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels.
    Bennett EP; Petersen BL; Johansen IE; Niu Y; Yang Z; Chamberlain CA; Met Ö; Wandall HH; Frödin M
    Nucleic Acids Res; 2020 Dec; 48(21):11958-11981. PubMed ID: 33170255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and Evaluation of Zinc Finger Nucleases.
    Ochiai H; Yamamoto T
    Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CRISPR/Cas9 technology in disease research and therapy: a review].
    Shi M; Shen Z; Zhang N; Wang L; Yu C; Yang Z
    Sheng Wu Gong Cheng Xue Bao; 2021 Apr; 37(4):1205-1228. PubMed ID: 33973436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basics of genome editing technology and its application in livestock species.
    Petersen B
    Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on genodermatoses using novel genome-editing tools.
    Lehmann J; Seebode C; Emmert S
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):783-789. PubMed ID: 28622433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
    Ma X; Zhu Q; Chen Y; Liu YG
    Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
    Okoli A; Okeke MI; Tryland M; Moens U
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29361752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of Zinc Finger Nucleases Through Structural Modeling Improves Genome Editing Efficiency in Cells.
    Katayama S; Watanabe M; Kato Y; Nomura W; Yamamoto T
    Adv Sci (Weinh); 2024 Jun; 11(23):e2310255. PubMed ID: 38600709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of CRISPR/Cas9-Generated Off-Target Effect by Integration-Defective Lentiviral Vector.
    Wang X; Wu Y; Yee JK
    Methods Mol Biol; 2021; 2162():243-260. PubMed ID: 32926387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral strategies for delivering genome editing enzymes.
    Li J; Røise JJ; He M; Das R; Murthy N
    Adv Drug Deliv Rev; 2021 Jan; 168():99-117. PubMed ID: 32931860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
    Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns regarding 'off-target' activity of genome editing endonucleases.
    Kadam US; Shelake RM; Chavhan RL; Suprasanna P
    Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.
    Zhang HX; Zhang Y; Yin H
    Mol Ther; 2019 Apr; 27(4):735-746. PubMed ID: 30803822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.